Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled human pneumococcal infection model in healthy Dutch adults
NL-OMON51807Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of phenethicillin in pneumococcal disease and Pneumococcal carriage (NPC), sponsored by Radboud University Medical Center. Primary endpoint: Percentage of volunteers infected with Streptococcus pneumoniae. Started May 2022; status: active, not recruiting.
02
Drugs
phenethicillin
03
Conditions
pneumococcal diseasePneumococcal carriage (NPC)
Beyond the preview
Go deeper on NL-OMON51807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51807.